Enhanced Inhibition of Neointimal Hyperplasia by Genetically Engineered Endothelial Progenitor Cells
Deling Kong(Nankai University), Victor J. Dzau(Duke Medical Center), Marco López-Ilasaca(Brigham and Women's Hospital), Richard E. Pratt(Duke Medical Center), Abeel A. Mangi(Brigham and Women's Hospital), Mark A. Perrella(Brigham and Women's Hospital), Chong C. Liew(Brigham and Women's Hospital), Luis G. Melo(Faculdade de Ciências Médicas de Minas Gerais), Lunan Zhang(Yangzhou University)
Cited by 289
Related Papers
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis.
|Proceedings of the National Academy of Sciences|1994|806
Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life.
|Circulation Research|1993|776
MicroRNA-Mediated In Vitro and In Vivo Direct Reprogramming of Cardiac Fibroblasts to Cardiomyocytes
|Circulation Research|2012|767
Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP.
|Proceedings of the National Academy of Sciences|1995|710
Natriuretic peptide system in human heart failure.
|Circulation|1993|461